Hospira takes pride in maintaining high quality standards by implementing current Good Manufacturing Practices and other globally recognized quality control procedures at each facility. Commercial manufacturing facilities, combined with product development services, create the synergy necessary to bring products to market.
Hospira product development provides a distinguished network of experienced scientists, regulatory experts and industry decision makers. These resources provide support throughout the latter stages of the development process as well as guidance on drug delivery systems designed to enhance existing product offerings. Hospira's One 2 One offers a full range of services for product development, including process development, ICH stability programs, production scale-up and validation and regulatory submission preparation.
Commercial manufacturing capabilities focus on each client's need for meeting aggressive timelines and providing flexibility in
drug delivery systems and batch sizes. Hospira's FDA registered facilities are dedicated to the manufacture of parenteral drug products. The One 2 One management and operations teams work closely with clients to deliver the product as requested, when requested.